Spinal Cord Injuries Clinical Trial
Official title:
Acute Intermittent Hypoxia and Body Weight Supported Treadmill Training: a Potential Therapy for Incomplete Spinal Cord Injury Patients
Spinal cord injury (SCI) interrupts descending synaptic pathways from brainstem premotor neurons to spinal motor neurons, thereby paralyzing muscles below the neurological level. In recent years, considerable evidence has demonstrated that acute intermittent hypoxia (AIH) elicits plasticity in the spinal cord and strengthens spare synaptic pathways which is expressed as respiratory and somatic functional recovery in animals and humans suffering from incomplete SCI. The fundamental hypothesis guiding this project is that AIH-induced motor plasticity can be "harnessed" to improve walking capacity in incomplete SCI patients, classified as C and D categories according to International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The inclusion criteria include patients > 18 years-old, with traumatic or non-traumatic, non-progressive incomplete SCI, onset > 6 months, neurological level C5-T12, with walking ability with or without assistive devices, without joint contractures, orthopedic injuries, osteoporosis, cutaneous lesions, cardiopulmonary complications and a body weight below 150 Kg. A randomized, triple-blind, placebo-controlled parallel design study will be done including 100% of patients fulfilling the criteria. Participants will receive repetitive acute intermittent hypoxia (rAIH: 15 episodes of 90 second 9% inspired oxygen interspersed with 90-second normoxia) or repetitive continued normoxia (rSham: 21% inspired oxygen) combined with 45 minutes body weight-supported treadmill training on 5 consecutive days and then three times per week for 3 weeks. Primary outcome measurement will be the 10-meter walking test. Secondary outcome measurements include the 6-minute walking test, timed up and go test, body/weight load, modified ashworth scale and visual analog scale. All outcomes will be measured before beginning the protocol (baseline), after five days of AIH/Sham (D5), weekly up to the end of the study (W2-W4), and a post-study follow-up for 2 weeks (F1-F2). Aditionally, cognitive assesment before and after the study will be performed using the "Figura compleja de Rey-Osterrieth" and the "Test de aprendizaje verbal España Complutense (TAVEC)". Repetitive AIH and body weight-supported treadmill training may represent a novel, safe, and noninvasive potential therapy to partially restore walking function in incomplete sub-acute and chronic SCI patients, a population with limited, if any, potential for improved function.
Currently, there is no "cure" for spinal cord injuries (SCI). Although the scientific
understanding of central nervous system (CNS) regeneration has advanced greatly in the past
twenty years, there are still many unknowns with regard to inducing successful regeneration,
especially with chronic SCI. A more realistic approach, based on currently available
knowledge, to improve the quality of life for a large proportion of the paralyzed population
may be to develop treatments that elicit partial functional recovery based on neuroplastic
potential of spared neural pathways. In this scenario, acute intermittent hypoxia (AIH)
enhances the inherit capacity for neuroplasticity and strengthens surviving synaptic inputs
onto spinal motorneurons, which trigger functional recovery following SCI in rats and humans
AIH-induced neuroplasticity has been extensively studied in phrenic motor nuclei (C3-C5)
through phrenic nerve recording preparations (Mitchell, 2007). Briefly, moderate AIH (3,
5-min hypoxic episodes; PaO2 35-45 mmHg; 5-min intervals) elicits phrenic long term
facilitation (pLTF), a type of memory present in the cervical spinal cord. The mechanism of
AIH-induced pLTF is that episodic hypoxia activates raphe serotonergic neurons that project
to phrenic motor nuclei. Spinal serotonin release during hypoxic episodes subsequently
activates serotonin type 2 (5-HT2) receptors coupled to Gq protein on or near phrenic motor
neurons, and initiates intracellular cascades that underlie pLTF . pLTF requires spinal
5-HT2 receptor activation , new synthesis of brain-derived neurotrophic factor (BDNF) and
activation of its high-affinity receptor tyrosine kinase (TrkB) followed by ERK MAP kinase
signaling. Although downstream signaling events from ERK are less clear, it is speculated
that glutamate receptors are phosphorylated, increasing glutamatergic transmission and
perhaps insertion within phrenic motor neurons, thereby establishing LTF.
Longer time domains of AIH, for example, daily acute intermittent hypoxia (i.e. dAIH, 10
episodes per day, 7 days) have shown to strengthen synaptic pathways to spinal motorneurons
and increase respiratory and locomotor recovery after cervical SCI in unanesthetized rats.
This functional improvement is accompanied by increased BDNF and TrkB levels within cervical
(C7) motor nuclei innervating the forelimb. Although the detailed mechanisms of the
functional recovery in somatic thoracic or lumbar motorneurons have not been verified, it
has been proposed that the same serotonin-dependent mechanisms facilitate motor output in
respiratory and non-respiratory motor nuclei.
The use of dAIH to improve limb function in humans with incomplete, chronic SCI has shown
promising results. A single presentation of AIH (15, 1-minute episodes of 9% O2 alternating
with 1-minute of 21% O2) in incomplete, chronic (>1 year) spinal cord injury patients,
classified as C or D according to the International Standards for Neurological
Classification of Spinal Cord Injury (ISNCSCI), increases the ability to voluntarily
generate plantar flexion 4 h post-hypoxia. In a randomized, double-blind,
placebo-controlled, crossover design study, the impact of daily AIH (15 episodes per day, 90
sec 9% O2, 60 sec normoxic interval, 5 consecutive days) combined with walking training was
studied in 19 chronic, incomplete SCI patients (ISNCSCI D). Daily AIH alone increased
walking speed 18% three days after treatment (10 m walk test); whereas dAIH combined with
walking training improved both walking speed and distance (37%) after 5 days and 1 week
post-dAIH. Importantly, no changes in cognitive function was observed after dAIH, suggesting
that this moderate dose of AIH is safe in humans.
Although dAIH (5 consecutive days of AIH) has demonstrated beneficial effects in incomplete
SCI patients, its effect last only up to one week; therefore, is important to design
extended protocols maintaining the initial functional effect of dAIH over time. Repetitive
AIH (rAIH) consisting of AIH three times per week (3×wAIH) for 10 weeks have demonstrated to
increase respiratory function and maintain the increased functional effect elicited by dAIH
in unanesthetized rats. Moreover, rAIH increases the expression of key molecules involved in
AIH-induced spinal plasticity in unanesthetized rats. Therefore, repetitive AIH may
represent a safe and effective strategy to enhance functional recovery after chronic
incomplete spinal cord injuries.
The protocol of intermittent hypoxia proposed in this project corresponds to a moderate dose
of intermittent hypoxia, which is the equivalent of climbing a mountain at 5000 meters
altitude. Abundant literature has demonstrated that moderate AIH (≥ 9% O2, < 15 cycles/day)
have several multi-systemic beneficial effects: reduces arterial hypertension, strengthens
innate immune responses, reduces inflammation, reduces body weight, increases aerobic
capacity, improves glucose tolerance, increases bone mineral density, enhances spatial
learning and memory, rescues ischemia-induced memory impairment, reduces symptoms of
depression, improves post-ischemic recovery of myocardial contractile function, and
increases respiratory capacity in chronic obstructive pulmonary disease. Moreover, moderate
repetitive AIH improves respiratory and somatic function after SCI, without adverse
consequences such as hypertension, neuronal cell loss and/or reactive gliosis or systemic
inflammation. Therefore, the potential beneficial effects of AIH are not only limited to
spinal cord injuries but include a wide scope of clinical conditions.
Combinatorial therapies, one of them being an activity-based training, can augment
plasticity after incomplete SCI. In rats with incomplete SCI, dAIH combined with ladder
walking leads to near complete recovery of ladder walking ability. Moreover, dAIH and
overground walking improve walking speed and distance in incomplete SCI patients ISNCSCI D.
Research studies in animals and humans have found that retraining after SCI using the
intrinsic physiologic properties of the nervous system can facilitate the recovery of
function. This potential for retraining is based on activity-dependent plasticity driven by
repetitive task-specific sensory input to spinal networks.
The most prominent and well-developed activity-based therapy (physical rehabilitation) to
date is locomotor training. The fundamental principles of locomotor training are built on
the premise of robustly approximating the sensorimotor experience of walking through
repetitive practice including: 1) maximize load bearing by the lower extremities and
minimize load bearing by the upper extremities, 2) optimize the sensory cues for walking, 3)
optimize the kinematics (i.e., trunk and extremities) for each motor task, and 4) maximize
recovery strategies and minimize compensatory mechanisms. The fundamental mechanisms
supporting this intervention have been derived largely from studies conducted in spinalised
animals. Specifically, treadmill training increases axonal regrowth and collateral sprouting
proximal to the lesion site in mice (Goldshmit et al., 2008), phosphorylation of Erk1/2 in
the motor cortex as well as the spinal cord injury area (Oh et al., 2009), expression of
brain-derived neurotrophic factor (BDNF) in the spinal cord, ameliorates muscle atrophy in
moderate contused SCI rats, and alters properties of spinal motor neurons. Body
weight-supported treadmill training (BWSTT) is based on optimizing sensory inputs relevant
to step training, repeated practice, and possible optimization of neuroplasticity.
Uncontrolled studies in acute and chronic SCI patients show within-subject improvements in
walking ability using BWSTT. Investigators propose that BWSTT therapy provide a behavioral
therapy that independently supports positive outcomes.
AIH combined with body weight-assisted training represents a simple and safe,
non-pharmacological method for enhancing neuroplasticity in the spinal cord and thus,
improving walking function in patients with incomplete spinal cord injuries. At the cellular
level, both BWSTT and AIH increase the expression of BDNF. BDNF has a wide repertoire of
neurotrophic and neuroprotective properties in the CNS and the periphery; namely, neuronal
protection and survival, neurite expression, axonal and dendritic growth and remodeling,
neuronal differentiation and synaptic plasticity such as synaptogenesis in arborizing axon
terminals, and synaptic transmission efficacy. Thus, BWSTT may serve as a catalyst in tandem
with repetitive AIH that when combined develop an even better response.
Currently, there are no approved therapies for chronic SCI; therefore, the approach
represents a promising new strategy to enhance function in patients with sub-acute and
chronic SCI, where the potential for further functional gains is limited.
Investigators propose a triple blind (patients, outcome assessors and stadistician)
randomized, placebo-controlled study testing the combined effect of intermittent hipoxia and
body weight-supported treadmill training in incoplete spinal cord injury patients.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06321172 -
Muscle and Bone Changes After 6 Months of FES Cycling
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05484557 -
Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury
|
N/A | |
Suspended |
NCT05542238 -
The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
|
N/A | |
Recruiting |
NCT05503316 -
The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System
|
N/A | |
Not yet recruiting |
NCT05506657 -
Early Intervention to Promote Return to Work for People With Spinal Cord Injury
|
N/A | |
Recruiting |
NCT03680872 -
Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System
|
N/A | |
Recruiting |
NCT04105114 -
Transformation of Paralysis to Stepping
|
Early Phase 1 | |
Completed |
NCT04221373 -
Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation
|
N/A | |
Completed |
NCT00116337 -
Spinal Cord Stimulation to Restore Cough
|
N/A | |
Completed |
NCT03898700 -
Coaching for Caregivers of Children With Spinal Cord Injury
|
N/A | |
Recruiting |
NCT04883463 -
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
|
N/A | |
Active, not recruiting |
NCT04881565 -
Losing Balance to Prevent Falls After Spinal Cord Injury (RBT+FES)
|
N/A | |
Completed |
NCT04864262 -
Photovoice for Spinal Cord Injury to Prevent Falls
|
N/A | |
Recruiting |
NCT04007380 -
Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI
|
N/A | |
Active, not recruiting |
NCT04544761 -
Resilience in Persons Following Spinal Cord Injury
|
||
Completed |
NCT03220451 -
Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients
|
N/A | |
Terminated |
NCT03170557 -
Randomized Comparative Trial for Persistent Pain in Spinal Cord Injury: Acupuncture vs Aspecific Needle Skin Stimulation
|
N/A | |
Recruiting |
NCT04811235 -
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
|
N/A | |
Recruiting |
NCT04736849 -
Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury
|
N/A |